Abstract
Clinical applications of current photodynamic therapy (PDT) agents are often limited by their low singlet oxygen (1 O 2) quantum yields, as well as by photobleaching and poor biocompatibility. Here we present a new PDT agent based on graphene quantum dots (GQDs) that can produce 1 O 2 via a multistate sensitization process, resulting in a quantum yield of ∼1.3, the highest reported for PDT agents. The GQDs also exhibit a broad absorption band spanning the UV region and the entire visible region and a strong deep-red emission. Through in vitro and in vivo studies, we demonstrate that GQDs can be used as PDT agents, simultaneously allowing imaging and providing a highly efficient cancer therapy. The present work may lead to a new generation of carbon-based nanomaterial PDT agents with overall performance superior to conventional agents in terms of 1 O 2 quantum yield, water dispersibility, photo-and pH-stability, and biocompatibility.
Original language | English |
---|---|
Article number | 4596 |
Journal | Nature Communications |
Volume | 5 |
DOIs | |
Publication status | Published - 8 Aug 2014 |
Externally published | Yes |